Physician profile
Hannah Nemec
NPI 1023472867
$3,267.09
in general payments reported to CMS, 2019-2025
38 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $900 · 2021: $429 · 2022: $327 · 2023: $54.51 · 2024: $533 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $743.44 | 2019-2020 | |
| Integra Lifesciences Corporation | $513.76 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axonics, INC. | $179.42 | 2020-2021 | |
| Allergan, INC. | $164.82 | 2019-2021 | |
| Davol INC. | $160.90 | 2021-2024 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $136.88 | 2020-2022 | |
| Acera Surgical, INC. | $136.16 | 2024-2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $117.60 | 2022 | |
| Avanos Medical | $107.92 | 2019-2021 | |
| Prytime Medical Devices, INC. | $84.81 | 2024 | Er-Reboa Plus |
| Polarityte, INC. | $77.64 | 2019-2020 | |
| Baxter Healthcare | $73.42 | 2019-2025 | Perclot |
| Intuitive Surgical, INC. | $66.99 | 2019-2020 | |
| Clr Medical, INC. | $55.00 | 2024 | Irrigator |
| Depuy Synthes Sales INC. | $53.35 | 2020 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $44.56 | 2024 | Progrip |
| Tela Bio, INC. | $40.38 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Vertex Pharmaceuticals Incorporated | $39.40 | 2025 | |
| Boston Scientific Corporation | $37.86 | 2024 | Spyglass Discover |
| Merck Sharp & Dohme LLC | $33.91 | 2024 | Recarbrio, Zerbaxa |
| Avita Medical Americas, LLC | $32.67 | 2025 | Permeaderm, Recell, Cohealyx |
| Octapharma USA, INC. | $32.23 | 2024 | Balfaxar |
| Portola Pharmaceuticals, LLC | $31.60 | 2019 | |
| Teleflex LLC | $28.41 | 2025 | Quikclot |
| Pfizer INC. | $26.27 | 2019 | |
| Biom'Up Sa | $26.05 | 2019 | |
| Kerecis Limited | $25.05 | 2021 | |
| Lifenet Health | $22.35 | 2025 | Theragenesis Wound Matrix |
| Z-Medica, LLC | $22.32 | 2019 | |
| Convatec INC. | $21.25 | 2024 | |
| Kci USA, INC. | $20.70 | 2020 | |
| Abbott Laboratories | $20.36 | 2024 | I-Stat |
| Chiesi USA, INC. | $18.98 | 2020 | |
| Csl Behring | $17.79 | 2021 | |
| La Jolla Pharmaceutical Company | $16.38 | 2025 | Giapreza |
| E.R. Squibb & Sons, L.L.C. | $12.81 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.27 | 2021 | |
| Ethicon US, LLC | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Nemec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.